The global digital pathology market revenue is expected to expand at a significant CAGR over the forecast period. Digital pathology also called as digital imaging, virtual microscopy or virtual slides uses computer-based technology for converting analog microscopic images into digital images. Increasing productivity, and automate image analysis and quality control process are major factors expected to drive growth of the global digital pathology market over the forecast period.
The global digital pathology market report has been segmented on the basis of technology, application, end-use, and region. On the basis of technology, the target market is segmented into whole slide imaging and telepathology. The telepathology segment is further sub-segmented into static and dynamic. The whole slide imaging technology segment is expected to register significant share in terms of revenue over the forecast period, owing to rising adoption of digital pathology systems, especially in the academic research activities.
On the basis of application, the target market is segmented into drug discovery & development, academic research, and disease diagnosis. On the basis of end-use, the target market is segmented into hospitals, private clinics, diagnostic labs, and research centers.
Request for the Sample Report Here: https://marketresearch.biz/report/digital-pathology-market/request-sample/
Based on the region the global digital pathology market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The market in North America is estimated to be highest share in terms of revenue over the forecast period, owing to increasing adoption of digital pathology for disease diagnosis, especially in the US. The market in Asia Pacific is expected to register significant CAGR in terms of revenue, owing to rising demand for novel treatment and improved healthcare facilities in developing countries such as India, China, and Japan in the region.
Key players operating in the global digital pathology market include Omnyx, LLC., 3DHISTECH Ltd., Definiens AG, Olympus Corporation, GE Healthcare Inc., Leica Biosystems Nussloch Gmbh, Philips Healthcare Informatics, Inc., Ventana Medical Systems, Inc., Objective Pathology, and Hamamatsu Photonics K.K.